First, Do No Harm: How Hippocratic AI Built a $3.5B Company by Saying No

In this episode of the IDAAHub Podcast on Startup & Innovation series, we break down how Hippocratic AI became one of the most-watched names in healthcare AI by doing something counterintuitive: deciding what its AI would refuse to do. No diagnosing. No prescribing. Just safe, patient-facing, non-diagnostic care built on a single principle — first, do no harm. We cover: The founder story: a serial entrepreneur with 25 years at the intersection of AI and healthcare The growth: a $50M pre-product seed round to a $3.5B valuation in about two and a half years, and 115M+ patient interactions with no reported safety issues What fresh 2026 patient-trust data now confirms about the bet they made two years early 3 transferable lessons: constraints as a moat, building with your customer, and solving for abundance instead of efficiency Whether you're building in healthcare, fintech, or anywhere AI meets a high-stakes decision, these lessons hold up. Sources: ZS Impact Institute 2026 Future of Health Report; PatientPoint 2026 Patient Confidence Index. 📧 Connect with IDAAHub  Follow us on:  LinkedIn: https://www.linkedin.com/company/idaahub/ YouTube: https://www.youtube.com/@IDAAHUB Spotify: https://open.spotify.com/show/3V8Vuhqkibej5fUwtwkUMx Apple Podcasts: https://podcasts.apple.com/us/podcast/the-idaa-hub-podcast-ai-ihealthcare/id1848710327 📧 Connect with Host  Host Deepti Kalghatgi: https://www.linkedin.com/in/deepti-kalghatgi/